Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Immunology

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/intimm/dxq027PMID 20410259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti‐interleukin‐31‐antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis

  2009cited by this paper
• Correlation of IL-31 serum levels with severity of atopic dermatitis.

  2008cited by this paper
• Molecular Mechanisms of Cytokine and Chemokine Release from Eosinophils Activated by IL-17A, IL-17F, and IL-23: Implication for Th17 Lymphocytes-Mediated Allergic Inflammation

  2008cited by this paper
• Regulated Expression of the IL-31 Receptor in Bronchial and Alveolar Epithelial Cells, Pulmonary Fibroblasts, and Pulmonary Macrophages

  2008cited by this paper
• Leptin‐mediated cytokine release and migration of eosinophils: Implications for immunopathophysiology of allergic inflammation

  2007cited by this paper
• Impaired PI3K/Akt Activation-Mediated NF-κB Inactivation Under Elevated TNF-α Is More Vulnerable to Apoptosis in Vitiliginous Keratinocytes

  2007cited by this paper
• Leukotriene B4 enhances tumour necrosis factor‐α‐induced CCL27 production in human keratinocytes

  2007cited by this paper
• Leukotriene B(4) enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes.

  2007cited by this paper
• Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells*

  2007cited by this paper
• Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes.

  2007cited by this paper
• Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils.

  2007cited by this paper
• Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.

  2006cited by this paper
• The contribution of keratinocytes to the pathogenesis of atopic dermatitis.

  2006cited by this paper
• IL‐25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation

  2006cited by this paper
• IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.

  2006cited by this paper
• Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients.

  2006cited by this paper
• Cytokines and chemokines orchestrate atopic skin inflammation.

  2006cited by this paper
• House dust mite allergen Der p 1 elevates the release of inflammatory cytokines and expression of adhesion molecules in co-culture of human eosinophils and bronchial epithelial cells.

  2006cited by this paper
• Involvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis

  2006cited by this paper
• IL-31: a new link between T cells and pruritus in atopic skin inflammation.

  2006cited by this paper
• Immune dysregulation in atopic dermatitis.

  2006cited by this paper
• Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis.

  2005cited by this paper
• CCL18 Is Expressed in Atopic Dermatitis and Mediates Skin Homing of Human Memory T Cells

  2005cited by this paper
• Clinical practice. Atopic dermatitis.

  2005cited by this paper
• ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation1

  2005cited by this paper
• CC Chemokine Ligand 18, An Atopic Dermatitis-Associated and Dendritic Cell-Derived Chemokine, Is Regulated by Staphylococcal Products and Allergen Exposure1

  2004cited by this paper
• Characterization of the Signaling Capacities of the Novel gp130-like Cytokine Receptor*

  2004cited by this paper
• Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages.

  2004cited by this paper
• Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

  2004cited by this paper
• Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling.

  2004cited by this paper
• New insights into atopic dermatitis.

  2004cited by this paper
• Eosinophil trafficking: new answers to old questions

  2004cited by this paper
• Eosinophils and atopic dermatitis

  2004cited by this paper
• Clinical applications of cytokine assays.

  2003cited by this paper
• Regulation of cytokine signaling and inflammation.

  2002cited by this paper
• IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line.

  2002cited by this paper
• IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.

  2002cited by this paper
• Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity.

  2001cited by this paper
• Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining

  2001cited by this paper
• Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein.

  2001cited by this paper
• MCP-1 and RANTES are mediators of acute and chronic inflammation.

  2001cited by this paper
• Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.

  2001cited by this paper
• The biology of chemokines and their receptors.

  2000cited by this paper
• Eosinophil cytokines.

  2000cited by this paper
• A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.

  2000cited by this paper
• Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists.

  1999cited by this paper
• Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes.

  1997cited by this paper
• Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice.

  1997cited by this paper
• The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis

  1993cited by this paper
• The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitis.

  1992cited by this paper
• Structure and Function of Leukocyte Integrins

  1990cited by this paper
• The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update.

  1990cited by this paper
• Blood eosinophilia in atopic dermatitis

  1990cited by this paper

• A preclinical study of device dependent therapeutic effects of cold atmospheric plasmas on atopic dermatitis induced by DNCB

  2026cites this paper
• Combined Systemic and Cutaneous Ovalbumin–Aluminum Sensitization Triggers Thermal Hyperalgesia, Spinal Gliosis, and Nociceptive Nerve Fibers Sprouting in Mice

  2025cites this paper
• Assessing the Molecular Validity of Spontaneous Lupus Mouse Models and Its Implication for Human Studies

  2025cites this paper
• Role of skin-homing t-cells in recurrent episodes of atopic dermatitis: a review

  2025cites this paper
• Comparing the Effects of Korean and Brazilian Propolis on Anti‐Atopic Dermatitis and the Related Mechanisms Through In Silico and In Vitro Analyses

  2024cites this paper
• Pyotraumatic dermatitis in dogs: etiology, characteristics of the course, and treatment approaches

  2024cites this paper
• A critical evaluation of nemolizumab for prurigo nodularis

  2024cites this paper
• TRPV1 Channel in Human Eosinophils: Functional Expression and Inflammatory Modulation

  2024cites this paper
• Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks

  2024cites this paper
• Cimifugin Mechanism of Action from Saposhnikovia divaricata in the Treatment of Atopic Dermatitis

  2024cites this paper
• STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis

  2024cites this paper
• Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome

  2024cites this paper
• Neutrophils in Atopic Dermatitis

  2024cites this paper
• Cytokine transcriptome profiling in acute experimental canine atopic dermatitis skin lesions after IL-31 inhibition with lokivetmab.

  2023cites this paper
• Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients

  2023cites this paper
• Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.

  2023cites this paper
• The JAK/STAT signalling pathway: Tiny molecules transforming therapeutics

  2023cites this paper
• Dermatomyositis with Eosinophils

  2023cites this paper
• The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective

  2023cites this paper
• The Role of Janus Kinase Signaling in the Pathology of Atopic Dermatitis.

  2023cites this paper
• Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach

  2023cites this paper
• Granzyme B in Epithelial Barrier Dysfunction and Related Skin Diseases.

  2022cites this paper
• Pain and Itch Control

  2022cites this paper
• Genetic variants affecting chemical mediated skin immunotoxicity

  2022cites this paper
• The role of cytokines in atopic dermatitis: a breakthrough in immunopathogenesis and treatment.

  2022cites this paper
• [[Translated article]]Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis

  2022cites this paper
• The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review

  2022cites this paper
• Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 – An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives

  2022cites this paper
• Ruxolitinib cream for the short-term treatment of mild-moderate atopic dermatitis

  2022cites this paper
• Atopic Dermatitis in Domestic Animals: What Our Current Understanding Is and How This Applies to Clinical Practice

  2021cites this paper
• Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues

  2021cites this paper
• Immunosensation: Neuroimmune Cross Talk in the Skin.

  2021cites this paper
• Involvement of Neuro-Immune Interactions in Pruritus With Special Focus on Receptor Expressions

  2021cites this paper
• Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus

  2021cites this paper
• IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses

  2021cites this paper
• The IL-4, IL-13 and IL-31 pathways in atopic dermatitis

  2021cites this paper
• Crisaborole prevents infiltration of neutrophils to suppress itch in a mouse model of atopic dermatitis

  2021cites this paper
• Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies

  2021cites this paper
• The Anti-Inflammatory and Anti-Pruritus Mechanisms of Huanglian Jiedu Decoction in the Treatment of Atopic Dermatitis

  2021cites this paper
• IL-31 and IL-31 receptor expression in acute experimental canine atopic dermatitis skin lesions.

  2021cites this paper
• In Vitro Models Mimicking Immune Response in the Skin

  2021cites this paper
• Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial

  2021cites this paper
• The interaction between the immune system and the peripheral sensory nerves in pruritus.

  2021cites this paper
• IL‐31 transgenic mice show reduced allergen‐induced lung inflammation

  2020cites this paper
• Effect of Hataedock Treatment on Epidermal Structure Maintenance through Intervention in the Endocannabinoid System

  2020cites this paper
• Current and emerging biologics for the treatment of pediatric atopic dermatitis

  2020cites this paper
• Keratinocytes: innate immune cells in atopic dermatitis

  2020cites this paper
• Interleukin‐31: The “itchy” cytokine in inflammation and therapy

  2020cites this paper
• Peroxisome Proliferator-Activated Receptors (PPARs) Activation as Therapeutic Targets in Skin Inflammation

  2019cites this paper
• Current and emerging biologic and small molecule therapies for atopic dermatitis

  2019cites this paper
• IL33: Roles in Allergic Inflammation and Therapeutic Perspectives

  2019cites this paper
• Commentary: Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD

  2019cites this paper
• Association of Interleukin-31 gene polymorphisms with risk of cryptorchidism in a Chinese population

  2019cites this paper
• Anti-Allergic Inflammatory Activity of Interleukin-37 Is Mediated by Novel Signaling Cascades in Human Eosinophils

  2018cites this paper
• Nemolizumab and Atopic Dermatitis: the Interaction Between Interleukin-31 and Interleukin-31 Receptor as a Potential Therapeutic Target for Pruritus in Patients With Atopic Dermatitis

  2018cites this paper
• Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T‐cell lymphoma

  2018cites this paper
• Cytokines: Role in Homeostasis and Disease States

  2018cites this paper
• CXCL1 activates TRPV1 via Gi/o protein and actin filaments

  2018cites this paper
• IL‐31: A new key player in dermatology and beyond

  2018cites this paper
• New mechanism underlying IL‐31–induced atopic dermatitis

  2018cites this paper
• Interleukin‐31 and interleukin‐31 receptor: New therapeutic targets for atopic dermatitis

  2018cites this paper
• Bleomycin Aggravates Atopic Dermatitis via Lung Inflammation in 2,4-Dinitrochlorobenzene-Induced NC/Nga Mice

  2018cites this paper
• Rôle de l'oncostatine M et des interleukines 6 et 31 dans l'inflammation cutanée chez la souris

  2017cites this paper
• Chemokine (C-X-C motif) ligand 1 (CXCL1) and chemokine (C-X-C motif) ligand 2 (CXCL2) modulate the activity of TRPV1+/IB4+ cultured rat dorsal root ganglia neurons upon short-term and acute application.

  2017cites this paper
• Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer

  2017cites this paper
• Profile of Serum Interleukin-31 Levels in Atopic Dermatitis

  2017cites this paper
• Interleukin 31 and skin diseases: A systematic review.

  2017cites this paper
• Diseases with Underlining Internal Conditions

  2017cites this paper
• Interleukin-31 pathway and its role in atopic dermatitis: a systematic review

  2017influential citation
• Identification of Novel Targetable Signaling Pathways in the Inherited Ichthyoses

  2017cites this paper
• Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients

  2017cites this paper
• IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function

  2016cites this paper
• The Effects of Prunus Armeniaca Linne Var Fractions on Th2 Cytokine Expression and Atopic Dermatitis of NC/Nga Mouse

  2016cites this paper
• Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.

  2016cites this paper
• The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus

  2016cites this paper
• Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation

  2016cites this paper
• Interleukin-31 expression and relation to disease severity in human asthma

  2016cites this paper
• Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis

  2016cites this paper
• Bee venom acupuncture alleviates trimellitic anhydride-induced atopic dermatitis-like skin lesions in mice

  2015cites this paper
• Increased levels of interleukin 31 (IL-31) in osteoporosis

  2015influential citation
• Role of cytokines and chemokines in itch.

  2015cites this paper
• NFAT1 and JunB Cooperatively Regulate IL-31 Gene Expression in CD4+ T Cells in Health and Disease

  2015cites this paper
• Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression*

  2015cites this paper
• IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31.

  2015cites this paper
• IL-6 Family and Cancer

  2014cites this paper
• Molecular Biology of Atopic Dermatitis

  2014cites this paper
• Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis.

  2014cites this paper
• IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease

  2014cites this paper
• Anti‐IL‐31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice

  2014cites this paper
• Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases

  2014cites this paper
• Host and environmental contribution to atopic dermatitis in dogs

  2014cites this paper
• An RNA interference based study for the role of ALDH1 in keratinocytes: DNA microarray, antibody–chip array and bioinformatics approaches

  2014cites this paper
• Genetic dysregulation in recurrent respiratory papillomatosis

  2014cites this paper
• New era of biologic therapeutics in atopic dermatitis

  2013influential citation
• Atopic eczema and allergies: Practical relevance for diagnostic work-up

  2013cites this paper
• Rutin suppresses atopic dermatitis and allergic contact dermatitis

  2013cites this paper
• Increased CCL18 expression in patients with cutaneous T‐cell lymphoma: association with disease severity and prognosis

  2013cites this paper
• Interleukin (IL)‐31 activates signal transducer and activator of transcription (STAT)‐1, STAT‐5 and extracellular signal‐regulated kinase 1/2 and down‐regulates IL‐12p40 production in activated human macrophages

  2013influential citation
• The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis

  2013cites this paper
• NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma

  2013cites this paper